☰

Michael Sereda, M.D. - Publications

Affiliations: 
Clinical Neurophysiology Georg-August-Universität Göttingen, Göttingen, Niedersachsen, Germany 
Tree Info Grants Similar researchers PubMed Report error

59 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Krauter D, Stausberg D, Hartmann TJ, Volkmann S, Kungl T, Rasche DA, Saher G, Fledrich R, Stassart RM, Nave KA, Goebbels S, Ewers D, Sereda MW. Targeting PI3K/Akt/mTOR signaling in rodent models of PMP22 gene-dosage diseases. Embo Molecular Medicine. PMID 38383802 DOI: 10.1038/s44321-023-00019-5  0.617
2023 Sundaram VK, Schütza V, Schröter NH, Backhaus A, Bilsing A, Joneck L, Seelbach A, Mutschler C, Gomez-Sanchez JA, Schäffner E, Sánchez EE, Akkermann D, Paul C, Schwagarus N, Müller S, ... ... Sereda MW, et al. Adipo-glial signaling mediates metabolic adaptation in peripheral nerve regeneration. Cell Metabolism. PMID 37989315 DOI: 10.1016/j.cmet.2023.10.017  0.545
2022 Düking T, Spieth L, Berghoff SA, Piepkorn L, Schmidke AM, Mitkovski M, Kannaiyan N, Hosang L, Scholz P, Shaib AH, Schneider LV, Hesse D, Ruhwedel T, Sun T, Linhoff L, ... ... Sereda M, et al. Ketogenic diet uncovers differential metabolic plasticity of brain cells. Science Advances. 8: eabo7639. PMID 36112685 DOI: 10.1126/sciadv.abo7639  0.529
2021 Götze T, Soto-Bernardini MC, Zhang M, Mießner H, Linhoff L, Brzózka MM, Velanac V, Dullin C, Ramos-Gomes F, Peng M, Husseini H, Schifferdecker E, Fledrich R, Sereda MW, Willig K, et al. Hyperactivity is a Core Endophenotype of Elevated Neuregulin-1 Signaling in Embryonic Glutamatergic Networks. Schizophrenia Bulletin. PMID 33871014 DOI: 10.1093/schbul/sbab027  0.602
2020 Berghoff SA, Spieth L, Sun T, Hosang L, Schlaphoff L, Depp C, Düking T, Winchenbach J, Neuber J, Ewers D, Scholz P, van der Meer F, Cantuti-Castelvetri L, Sasmita AO, Meschkat M, ... ... Sereda MW, et al. Microglia facilitate repair of demyelinated lesions via post-squalene sterol synthesis. Nature Neuroscience. PMID 33349711 DOI: 10.1038/s41593-020-00757-6  0.499
2020 Prukop T, Wernick S, Boussicault L, Ewers D, Jäger K, Adam J, Winter L, Quintes S, Linhoff L, Barrantes-Freer A, Bartl M, Czesnik D, Zschüntzsch J, Schmidt J, Primas G, ... ... Sereda MW, et al. Synergistic PXT3003 therapy uncouples neuromuscular function from dysmyelination in male Charcot-Marie-Tooth disease type 1A (CMT1A) rats. Journal of Neuroscience Research. PMID 32588471 DOI: 10.1002/jnr.24679  0.577
2020 Siems SB, Jahn O, Eichel MA, Kannaiyan N, Wu LMN, Sherman DL, Kusch K, Hesse D, Jung RB, Fledrich R, Sereda MW, Rossner MJ, Brophy PJ, Werner HB. Proteome profile of peripheral myelin in healthy mice and in a neuropathy model. Elife. 9. PMID 32130108 DOI: 10.7554/eLife.51406  0.733
2019 Joseph S, Vingill S, Jahn O, Fledrich R, Werner HB, Katona I, Möbius W, Mitkovski M, Huang Y, Weis J, Sereda MW, Schulz JB, Nave KA, Stegmüller J. Myelinating glia-specific deletion of Fbxo7 in mice triggers axonal degeneration in the central nervous system together with peripheral neuropathy. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 31085610 DOI: 10.1523/JNEUROSCI.3094-18.2019  0.724
2019 Fledrich R, Akkermann D, Schütza V, Abdelaal TA, Hermes D, Schäffner E, Soto-Bernardini MC, Götze T, Klink A, Kusch K, Krueger M, Kungl T, Frydrychowicz C, Möbius W, Brück W, ... ... Sereda MW, et al. Publisher Correction: NRG1 type I dependent autoparacrine stimulation of Schwann cells in onion bulbs of peripheral neuropathies. Nature Communications. 10: 1840. PMID 30992451 DOI: 10.1038/s41467-019-09886-4  0.41
2019 Fledrich R, Akkermann D, Schütza V, Abdelaal TA, Hermes D, Schäffner E, Soto-Bernardini MC, Götze T, Klink A, Kusch K, Krueger M, Kungl T, Frydrychowicz C, Möbius W, Brück W, ... ... Sereda MW, et al. NRG1 type I dependent autoparacrine stimulation of Schwann cells in onion bulbs of peripheral neuropathies. Nature Communications. 10: 1467. PMID 30931926 DOI: 10.1038/s41467-019-09385-6  0.575
2019 Prukop T, Stenzel J, Wernick S, Kungl T, Mroczek M, Adam J, Ewers D, Nabirotchkin S, Nave KA, Hajj R, Cohen D, Sereda MW. Early short-term PXT3003 combinational therapy delays disease onset in a transgenic rat model of Charcot-Marie-Tooth disease 1A (CMT1A). Plos One. 14: e0209752. PMID 30650121 DOI: 10.1371/journal.pone.0209752  0.567
2018 Fledrich R, Abdelaal T, Rasch L, Bansal V, Schütza V, Brügger B, Lüchtenborg C, Prukop T, Stenzel J, Rahman RU, Hermes D, Ewers D, Möbius W, Ruhwedel T, Katona I, ... ... Sereda MW, et al. Targeting myelin lipid metabolism as a potential therapeutic strategy in a model of CMT1A neuropathy. Nature Communications. 9: 3025. PMID 30072689 DOI: 10.1038/S41467-018-05420-0  0.668
2017 Kleinecke S, Richert S, de Hoz L, Brügger B, Kungl T, Asadollahi E, Quintes S, Blanz J, McGonigal R, Naseri K, Sereda MW, Sachsenheimer T, Lüchtenborg C, Möbius W, Willison H, et al. Peroxisomal dysfunctions cause lysosomal storage and axonal Kv1 channel redistribution in peripheral neuropathy. Elife. 6. PMID 28470148 DOI: 10.7554/eLife.23332  0.657
2017 Günther R, Balck A, Koch JC, Nientiedt T, Sereda M, Bähr M, Lingor P, Tönges L. Rho Kinase Inhibition with Fasudil in the SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis-Symptomatic Treatment Potential after Disease Onset. Frontiers in Pharmacology. 8: 17. PMID 28197100 DOI: 10.3389/Fphar.2017.00017  0.318
2016 Sociali G, Visigalli D, Prukop T, Cervellini I, Mannino E, Venturi C, Bruzzone S, Sereda MW, Schenone A. Tolerability and efficacy study of P2X7 inhibition in experimental Charcot-Marie-Tooth type 1A (CMT1A) neuropathy. Neurobiology of Disease. PMID 27431093 DOI: 10.1016/j.nbd.2016.07.017  0.404
2016 Quintes S, Brinkmann BG, Ebert M, Fröb F, Kungl T, Arlt FA, Tarabykin V, Huylebroeck D, Meijer D, Suter U, Wegner M, Sereda MW, Nave KA. Zeb2 is essential for Schwann cell differentiation, myelination and nerve repair. Nature Neuroscience. PMID 27294512 DOI: 10.1038/Nn.4321  0.633
2015 Patzig J, Kusch K, Fledrich R, Eichel MA, Lüders KA, Möbius W, Sereda MW, Nave KA, Martini R, Werner HB. Proteolipid protein modulates preservation of peripheral axons and premature death when myelin protein zero is lacking. Glia. PMID 26393339 DOI: 10.1002/glia.22922  0.732
2015 Epplen DB, Prukop T, Nientiedt T, Albrecht P, Arlt FA, Stassart RM, Kassmann CM, Methner A, Nave KA, Werner HB, Sereda MW. Curcumin therapy in a Plp1 transgenic mouse model of Pelizaeus-Merzbacher disease. Annals of Clinical and Translational Neurology. 2: 787-96. PMID 26339673 DOI: 10.1002/Acn3.219  0.642
2015 Martini R, Walter MC, Sereda M, Young P, Nave KA, Van Broeckhoven C, Lupski JR. Prof. Dr. Bernd Rautenstrauss (1959-2015) Pioneer in CMT Genetics Neuromuscular Disorders. 25: 725-726. DOI: 10.1016/J.Nmd.2015.07.011  0.43
2014 Chumakov I, Milet A, Cholet N, Primas G, Boucard A, Pereira Y, Graudens E, Mandel J, Laffaire J, Foucquier J, Glibert F, Bertrand V, Nave KA, Sereda MW, Vial E, et al. Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy. Orphanet Journal of Rare Diseases. 9: 201. PMID 25491744 DOI: 10.1186/S13023-014-0201-X  0.639
2014 Avenali L, Narayanan P, Rouwette T, Cervellini I, Sereda M, Gomez-Varela D, Schmidt M. Annexin A2 regulates TRPA1-dependent nociception. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 14506-16. PMID 25355205 DOI: 10.1523/Jneurosci.1801-14.2014  0.302
2014 Fledrich R, Stassart RM, Klink A, Rasch LM, Prukop T, Haag L, Czesnik D, Kungl T, Abdelaal TA, Keric N, Stadelmann C, Brück W, Nave KA, Sereda MW. Soluble neuregulin-1 modulates disease pathogenesis in rodent models of Charcot-Marie-Tooth disease 1A. Nature Medicine. 20: 1055-61. PMID 25150498 DOI: 10.1038/nm.3664  0.676
2014 Prukop T, Epplen DB, Nientiedt T, Wichert SP, Fledrich R, Stassart RM, Rossner MJ, Edgar JM, Werner HB, Nave KA, Sereda MW. Progesterone antagonist therapy in a Pelizaeus-Merzbacher mouse model. American Journal of Human Genetics. 94: 533-46. PMID 24680886 DOI: 10.1016/j.ajhg.2014.03.001  0.732
2014 Tönges L, Günther R, Suhr M, Jansen J, Balck A, Saal KA, Barski E, Nientied T, Götz AA, Koch JC, Mueller BK, Weishaupt JH, Sereda MW, Hanisch UK, Bähr M, et al. Rho kinase inhibition modulates microglia activation and improves survival in a model of amyotrophic lateral sclerosis. Glia. 62: 217-32. PMID 24311453 DOI: 10.1002/glia.22601  0.307
2013 Stassart RM, Fledrich R, Velanac V, Brinkmann BG, Schwab MH, Meijer D, Sereda MW, Nave KA. A role for Schwann cell-derived neuregulin-1 in remyelination. Nature Neuroscience. 16: 48-54. PMID 23222914 DOI: 10.1038/nn.3281  0.666
2013 Schwab MH, Sereda MW, Nave KA. Neuron-Glial Interactions: Schwann Cells Comprehensive Developmental Neuroscience: Patterning and Cell Type Specification in the Developing Cns and Pns. 851-869. DOI: 10.1016/B978-0-12-397265-1.00089-7  0.417
2012 Fünfschilling U, Supplie LM, Mahad D, Boretius S, Saab AS, Edgar J, Brinkmann BG, Kassmann CM, Tzvetanova ID, Möbius W, Diaz F, Meijer D, Suter U, Hamprecht B, Sereda MW, et al. Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature. 485: 517-21. PMID 22622581 DOI: 10.1038/Nature11007  0.788
2012 Fledrich R, Stassart RM, Sereda MW. Murine therapeutic models for Charcot-Marie-Tooth (CMT) disease. British Medical Bulletin. 102: 89-113. PMID 22551516 DOI: 10.1093/bmb/lds010  0.32
2012 Goebbels S, Oltrogge JH, Wolfer S, Wieser GL, Nientiedt T, Pieper A, Ruhwedel T, Groszer M, Sereda MW, Nave KA. Genetic disruption of Pten in a novel mouse model of tomaculous neuropathy. Embo Molecular Medicine. 4: 486-99. PMID 22488882 DOI: 10.1002/emmm.201200227  0.581
2012 Makoukji J, Belle M, Meffre D, Stassart R, Grenier J, Shackleford G, Fledrich R, Fonte C, Branchu J, Goulard M, de Waele C, Charbonnier F, Sereda MW, Baulieu EE, Schumacher M, et al. Lithium enhances remyelination of peripheral nerves. Proceedings of the National Academy of Sciences of the United States of America. 109: 3973-8. PMID 22355115 DOI: 10.1073/Pnas.1121367109  0.368
2012 Fledrich R, Schlotter-Weigel B, Schnizer TJ, Wichert SP, Stassart RM, Meyer zu Hörste G, Klink A, Weiss BG, Haag U, Walter MC, Rautenstrauss B, Paulus W, Rossner MJ, Sereda MW. A rat model of Charcot-Marie-Tooth disease 1A recapitulates disease variability and supplies biomarkers of axonal loss in patients. Brain : a Journal of Neurology. 135: 72-87. PMID 22189569 DOI: 10.1093/brain/awr322  0.637
2011 Gess B, Röhr D, Fledrich R, Sereda MW, Kleffner I, Humberg A, Nowitzki J, Strecker JK, Halfter H, Young P. Sodium-dependent vitamin C transporter 2 deficiency causes hypomyelination and extracellular matrix defects in the peripheral nervous system. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 17180-92. PMID 22114285 DOI: 10.1523/JNEUROSCI.3457-11.2011  0.325
2011 Kassmann CM, Quintes S, Rietdorf J, Möbius W, Sereda MW, Nientiedt T, Saher G, Baes M, Nave KA. A role for myelin-associated peroxisomes in maintaining paranodal loops and axonal integrity. Febs Letters. 585: 2205-11. PMID 21620837 DOI: 10.1016/j.febslet.2011.05.032  0.661
2011 Meyer zu Horste G, Miesbach TA, Muller JI, Fledrich R, Stassart RM, Kieseier BC, Coleman MP, Sereda MW. The Wlds transgene reduces axon loss in a Charcot-Marie-Tooth disease 1A rat model and nicotinamide delays post-traumatic axonal degeneration. Neurobiology of Disease. 42: 1-8. PMID 21168501 DOI: 10.1016/j.nbd.2010.12.006  0.474
2009 Leal A, Huehne K, Bauer F, Sticht H, Berger P, Suter U, Morera B, Del Valle G, Lupski JR, Ekici A, Pasutto F, Endele S, Barrantes R, Berghoff C, Berghoff M, ... ... Sereda MW, et al. Identification of the variant Ala335Val of MED25 as responsible for CMT2B2: molecular data, functional studies of the SH3 recognition motif and correlation between wild-type MED25 and PMP22 RNA levels in CMT1A animal models. Neurogenetics. 10: 375-376. PMID 25488817 DOI: 10.1007/s10048-009-0213-1  0.404
2009 Merkler D, Klinker F, Jürgens T, Glaser R, Paulus W, Brinkmann BG, Sereda MW, Stadelmann-Nessler C, Guedes RC, Brück W, Liebetanz D. Propagation of spreading depression inversely correlates with cortical myelin content. Annals of Neurology. 66: 355-65. PMID 19798729 DOI: 10.1002/ana.21746  0.3
2009 Leal A, Huehne K, Bauer F, Sticht H, Berger P, Suter U, Morera B, Del Valle G, Lupski JR, Ekici A, Pasutto F, Endele S, Barrantes R, Berghoff C, Berghoff M, ... ... Sereda MW, ... ... Sereda M, et al. Identification of the variant Ala335Val of MED25 as responsible for CMT2B2: molecular data, functional studies of the SH3 recognition motif and correlation between wild-type MED25 and PMP22 RNA levels in CMT1A animal models. Neurogenetics. 10: 275-87. PMID 19290556 DOI: 10.1007/S10048-009-0183-3  0.532
2009 Schardt A, Brinkmann BG, Mitkovski M, Sereda MW, Werner HB, Nave KA. The SNARE protein SNAP-29 interacts with the GTPase Rab3A: Implications for membrane trafficking in myelinating glia. Journal of Neuroscience Research. 87: 3465-79. PMID 19170188 DOI: 10.1002/jnr.22005  0.671
2009 Fledrich R, Schnizer T, Schlotter-Weigel B, Schneiderat P, Weiss B, Meyer zu Hörste G, Stassart R, Brinkmann B, Walter M, Rautenstrauss B, Paulus W, Rossner M, Nave K, Sereda M. Erkrankungsmarker bei der Charcot-Marie-Tooth Erkrankung 1A Aktuelle Neurologie. 36. DOI: 10.1055/S-0029-1238329  0.592
2009 Sereda M, Weiss B, Fledrich R, Meyer zu Hörste G, Stassart R, Brinkmann B, Nave K. Experimentelle Therapien bei hereditären Neuropathien Aktuelle Neurologie. 36. DOI: 10.1055/S-0029-1238327  0.4
2008 Brinkmann BG, Agarwal A, Sereda MW, Garratt AN, Müller T, Wende H, Stassart RM, Nawaz S, Humml C, Velanac V, Radyushkin K, Goebbels S, Fischer TM, Franklin RJ, Lai C, et al. Neuregulin-1/ErbB signaling serves distinct functions in myelination of the peripheral and central nervous system. Neuron. 59: 581-95. PMID 18760695 DOI: 10.1016/j.neuron.2008.06.028  0.684
2008 Wessig C, Jestaedt L, Sereda MW, Bendszus M, Stoll G. Gadofluorine M-enhanced magnetic resonance nerve imaging: comparison between acute inflammatory and chronic degenerative demyelination in rats. Experimental Neurology. 210: 137-43. PMID 18061168 DOI: 10.1016/j.expneurol.2007.10.014  0.331
2007 Nave KA, Sereda MW, Ehrenreich H. Mechanisms of disease: inherited demyelinating neuropathies--from basic to clinical research. Nature Clinical Practice. Neurology. 3: 453-64. PMID 17671523 DOI: 10.1038/ncpneuro0583  0.653
2007 Meyer zu Horste G, Prukop T, Liebetanz D, Mobius W, Nave KA, Sereda MW. Antiprogesterone therapy uncouples axonal loss from demyelination in a transgenic rat model of CMT1A neuropathy. Annals of Neurology. 61: 61-72. PMID 17262851 DOI: 10.1002/ana.21026  0.629
2006 Sereda MW, Nave KA. Animal models of Charcot-Marie-Tooth disease type 1A. Neuromolecular Medicine. 8: 205-16. PMID 16775377 DOI: 10.1385/NMM:8:1:205  0.626
2006 Meyer zu Hörste G, Prukop T, Nave KA, Sereda MW. Myelin disorders: Causes and perspectives of Charcot-Marie-Tooth neuropathy. Journal of Molecular Neuroscience : Mn. 28: 77-88. PMID 16632877 DOI: 10.1385/JMN:28:1:77  0.617
2005 Vigo T, Nobbio L, Hummelen PV, Abbruzzese M, Mancardi G, Verpoorten N, Verhoeven K, Sereda MW, Nave KA, Timmerman V, Schenone A. Experimental Charcot-Marie-Tooth type 1A: a cDNA microarrays analysis. Molecular and Cellular Neurosciences. 28: 703-14. PMID 15797717 DOI: 10.1016/J.Mcn.2004.11.016  0.598
2005 Meyer zu Hörste G, Prukop T, Sereda M, Nave K. Novel therapeutic strategies and towards a disease severity marker in a model of Charcot-Marie-Tooth disease 1A (CMT1A) Aktuelle Neurologie. 32. DOI: 10.1055/s-2005-919616  0.469
2005 Meyer zu Hörste G, Prukop T, Nave K, Sereda M. Axon-glia Kommunikation: experimentelle Therapien hereditärer Neuropathien Aktuelle Neurologie. 32. DOI: 10.1055/s-2005-919195  0.57
2005 Meyer zu Hörste G, Sereda MW. Genetic defects of myelination: Molecular pathogenesis of the Charcot-Marie-Tooth disease (CMT1A) | Genetische Defekte der Myelinbildung: Molekulare Pathogenese der Charcot-Marie-Tooth Neuropathie (CMT1A) Neuroforum. 11: 25-30.  0.355
2004 Grandis M, Leandri M, Vigo T, Cilli M, Sereda MW, Gherardi G, Benedetti L, Mancardi G, Abbruzzese M, Nave KA, Nobbio L, Schenone A. Early abnormalities in sciatic nerve function and structure in a rat model of Charcot-Marie-Tooth type 1A disease. Experimental Neurology. 190: 213-23. PMID 15473994 DOI: 10.1016/j.expneurol.2004.07.008  0.621
2004 Michailov GV, Sereda MW, Brinkmann BG, Fischer TM, Haug B, Birchmeier C, Role L, Lai C, Schwab MH, Nave KA. Axonal neuregulin-1 regulates myelin sheath thickness. Science (New York, N.Y.). 304: 700-3. PMID 15044753 DOI: 10.1126/science.1095862  0.638
2003 Sereda MW, Meyer zu Hörste G, Suter U, Uzma N, Nave KA. Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A). Nature Medicine. 9: 1533-7. PMID 14608378 DOI: 10.1038/Nm957  0.626
2001 Schneider S, Bosse F, D'Urso D, Muller H, Sereda MW, Nave K, Niehaus A, Kempf T, Schnolzer M, Trotter J. The AN2 protein is a novel marker for the Schwann cell lineage expressed by immature and nonmyelinating Schwann cells. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 920-33. PMID 11157078  0.43
2000 Niemann S, Sereda MW, Suter U, Griffiths IR, Nave KA. Uncoupling of myelin assembly and schwann cell differentiation by transgenic overexpression of peripheral myelin protein 22. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 4120-8. PMID 10818147 DOI: 10.1111/J.1529-8027.2000.22-36.X  0.684
1999 Niemann S, Sereda MW, Rossner M, Stewart H, Suter U, Meinck HM, Griffiths IR, Nave KA. The "CMT Rat": Peripheral Neuropathy and Dysmyelination Caused by Transgenic Overexpression of PMP22. Annals of the New York Academy of Sciences. 883: 254-261. PMID 29086932 DOI: 10.1111/J.1749-6632.1999.Tb08587.X  0.757
1999 Niemann S, Sereda MW, Rossner M, Stewart H, Suter U, Meinck HM, Griffiths IR, Nave KA. The "CMT rat": peripheral neuropathy and dysmyelination caused by transgenic overexpression of PMP22. Annals of the New York Academy of Sciences. 883: 254-61. PMID 10586250  0.757
1998 Werner H, Jung M, Klugmann M, Sereda M, Griffiths IR, Nave KA. Mouse models of myelin diseases. Brain Pathology (Zurich, Switzerland). 8: 771-93. PMID 9804383 DOI: 10.1111/J.1750-3639.1998.Tb00200.X  0.795
1996 Sereda M, Griffiths I, Pühlhofer A, Stewart H, Rossner MJ, Zimmerman F, Magyar JP, Schneider A, Hund E, Meinck HM, Suter U, Nave KA. A transgenic rat model of Charcot-Marie-Tooth disease. Neuron. 16: 1049-60. PMID 8630243 DOI: 10.1016/S0896-6273(00)80128-2  0.767
Show low-probability matches.